CanSino Biologics Inc. (CANSINOBIO) has announced that its Board of Directors will convene on 27 October 2026 to consider and approve the company’s third-quarter results for the nine months ended 30 September 2026, along with the related public disclosure.\n\nThe meeting will address the consolidated financial performance of the company and its subsidiaries for the period. Any resolutions passed—including the adoption and release of the results—are expected to be published shortly after the meeting.\n\nThe Board currently comprises three executive directors (Dr. Xuefeng Yu, Dr. Shou Bai Chao and Ms. Jing Wang), one non-executive director (Mr. Chi Shing Li), and three independent non-executive directors (Mr. Yiu Leung Andy Cheung, Mr. Man Cho and Ms. Xuefeng Ji). The meeting will be chaired by Dr. Xuefeng Yu.